Detalhe da pesquisa
1.
Reduced prophylactic effect of tixagevimab-cilgavimab in patients with hematological malignancies and without antibody response after SARS-COV-2 vaccination.
Eur J Haematol
; 111(4): 668-670, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461815
2.
Progressive Multifocal Leukoencephalopathy in B-CLL Successfully Treated With Venetoclax and Pembrolizumab.
Hemasphere
; 6(6): e723, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747841